PARK - Preventing Asthma in High Risk Kids

National Institute of Allergy and Infectous Diseases

Does your child wheeze?

Studies show that up to 80% of children ages two to three years old who have allergies and multiple wheezing episodes will eventually develop asthma. What if there were a way to reduce the risk of asthma developing in young children?

Researchers across the United States are studying whether Xolair® can help prevent lasting, severe asthma and new allergies from developing, or reduce the severity of existing ones, in preschool-age children. If your child is two or three years old, he or she may be eligible to participate in this clinical study.

The PARK study is being conducted across the U.S. at the following locations:

Atlanta, GA
Boston, MA
Boston Children’s Hospital
Asthma Clinical Research Center
857-218-5336
asthma@childrens.harvard.edu
Chicago, IL
Lurie Children’s
Michelle Catalano
312-227-6455
MCatalano@luriechildrens.org
Houston, TX
Texas Children's Hospital
Sopar Seributra
832-824-1324
pars@bcm.edu
Indianapolis, IN
Riley Hospital for Children
Lori Shively,RN, CCRC
317-278-7121
lashivel@iu.edu
Madison, WI
Phoenix, AZ
San Diego, CA
Rady Children’s
Diba Mortazavi
858-966-1700 Ext. 223422
dmortazavi@health.ucsd.edu
St. Louis, MO
Washington University
Tina Norris
314-286-1173
parkasthma@wustl.edu
Tucson, AZ
Washington, D.C.

CONTACT
US NOW

to learn more about
participating in the
PARK study

857-218-5336
asthma@childrens.harvard.edu

CONTACT
US NOW

to learn more about
participating in the
PARK study

857-218-5336
asthma@childrens.harvard.edu